课题基金 / 基金详情

Objective Measurement and Biological Basis of Anxiety Assessed by Frontal Midline Theta Activity (Fm<theta>)

Objective Measurement and Biological Basis of Anxiety Assessed by Frontal Midline Theta Activity (Fm<theta>)
通过额叶中线 Theta 活动 (Fm<theta>) 评估焦虑的客观测量和生物学基础
批准号:
60480262
负责人:
MIZUKI Yasushi
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1985
资助国家:
日本
项目状态:
已结题
起止时间:
1985 至 1987

项目摘要

项目成果

MIZUKI Yasushi的其他基金

相似基金

相关文献

中文摘要
翻译
在执行脑力任务的过程中,额叶中线区域的独特的theta节奏被称为fm&lt;theta&gt;。众所周知,焦虑的缓解可能与FM&lt;theta&gt;的出现有关。本研究以FM&lt;theta&gt;为指标,探讨焦虑的客观测量及其生物学基础,并对有FM&lt;theta&gt;的男生(n=12)和无FM&lt;theta&gt;的男生(n=12)的血浆儿茶酚胺反应进行研究。观察两组患者休息时、计算前、计算中、计算后的血浆儿茶酚胺含量、Fm&lt、Theta、Gt出现时间及焦虑评分。Fm&lt;theta&gt;出现组的儿茶酚胺浓度始终低于不出现组。不出现组焦虑缓解的特点是NA周转减少,而出现组焦虑的减少涉及DA Turn…的增加FM&lt;theta&gt;外观组(n=9)和非外观组(n=9)的受试者采用双盲交叉设计,分别给予溴隐亭2.5 mg、舒必利50 mg和安慰剂。分别于给药前和给药后1h测定Fm&lt;theta&gt;出现情况、焦虑评分和血浆儿茶酚胺含量。使用可乐定0.15 mg、育亨宾5 mg和安慰剂也进行了类似的实验。对28例神经症患者和35例精神分裂症患者进行了FM&lt;theta&Gt;出现组的FM&lt;theta&gt;出现,直到连续2周出现FM&lt;theta&gt;出现前、后的临床症状评定,并测定了血浆儿茶酚胺的含量。随着症状的改善,大量神经症患者出现Fm&lt;theta&Gt;和NA活动抑制。将精神分裂症患者分为两组,即Fm&lt;theta&gt;出现组和不出现组。FM&lt;theta&Gt;患者对抗精神病药物治疗有反应,阳性症状有所减少。较少
英文摘要
The distinct theta rhythm in the frontal midline area during performance of mental tasks has been called Fm<theta>. It is well known that the relief from anxiety might be involved in the appearance of Fm<theta>. In the present study, the objective measurement and the biological basis of anxiety were investigated by using Fm<theta> as an index.The plasma catecholamine responses to mental stress were studied using male students with (n=12) and without (n=12) Fm<theta>. The contents of plasma catecholamines, the appearance time of Fm<theta> and the anxiety scores of two groups were examined during the rest, and before, during and after the calculation. The concentrations of catecholamines in the Fm<theta> appearance group showed lower levels at all times compared to those in the non appearance group. The relief from anxiety in the non appearance group was characterized by a decrease of NA turnover while a decrease of anxiety in the Fm<theta> appearance group involved an increase of DA tur … More nover.The subjects in the Fm<theta> appearance group (n=9) and in the non appearance group (n=9) were given bromocriptine 2.5 mg, sulpiride 50 mg and placebo in a double-blind, crossover design. The appearance of Fm<theta>, the scores of anxiety and the plasma catecholamines were measured before and 1 hr after the drug administration. The similar experiment using clonidine 0.15 mg, yohimbine 5 mg and placebo was also performed. Both an increase of Fm<theta> and a decrease of anxiety in the Fm<theta> appearance group were shown by the stimulation of DA activity, while those in the non appearance group were indicated by the inhibition od DA or NA activity.Twenty eight neurotics and 35 schizophrenics were examined the appearance of Fm<Theta> and the clinical evaluation of symptoms once weekly until Fm<theta> appeared in 2 consecutive weeks, and the plasma catecholamines were also measured before and after the study. A large number of neurotics showed the appearance of Fm<theta> and the inhibition of NA activity according to the improvement of their symptoms. Schizophrenics were divided into two groups, i.e., the Fm<theta> appearance group and the non appearance group. The patients with Fm<theta> responded to the neuroleptics treatment and indicated a decrease of positive symptoms. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Mizuki, Y.: "Differential responses to mental stress in high- and low-anxious students assessed by frontal midline theta activity." Neuropsychobiology.
Mizuki, Y.:“通过额叶中线 theta 活动评估高焦虑和低焦虑学生对精神压力的不同反应。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizuki, Y.: Neuropsychobiology.
Mizuki, Y.:神经心理生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    The Role of Central Purin, Benzodiazepine and GABA Systems on Development of Tolerance and Reverse Tolerance to Dopamine-Mimetic Drugs.
    • 批准号:
      01570608
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1989
    • 负责人:
      MIZUKI Yasushi
    • 依托单位:
    海外基金